内镜引导下咽鼓管吹张激素给药治疗分泌性中耳炎效果观察  

Effect of Endoscope-Guided Hormone Administration on Secretory Otitis Media

作　　者：孙源昊 李文龙 代兵 于慧媛 常江 SUN Yuanhao;LI Wenlong;DAI Bing;YU Huiyuan;CHANG Jiang(Department of Otolaryngology,Shenzhen Samii Medical Center,Shenzhen Guangdong 518118,China)

机构地区：[1]深圳市萨米医疗中心耳鼻咽喉科,广东深圳518118

出　　处：《中国卫生标准管理》2023年第6期109-112,共4页China Health Standard Management

摘　　要：目的分析内镜引导下咽鼓管吹张激素给药在分泌性中耳炎患者中的应用效果。方法选择深圳市萨米医疗中心2021年1月—2022年12月收治的分泌性中耳炎患者中抽取94例作为研究对象,随机数字表法分为对照组47例与观察组47例。对照组采用常规治疗以及波氏法咽鼓管吹张治疗,观察组采用常规治疗联合内镜引导下咽鼓管吹张激素给药。对比观察两组患者治疗前后7项咽鼓管功能障碍症状评分量表(the seven-item Eustachian tube dysfunction questionnaire,ETDQ-7)评分、治疗有效率、并发症不良反应发生率以及疾病复发情况。结果治疗前,两组患者ETDQ-7评分组间比较差异无统计学意义(P>0.05);治疗后,两组患者ETDQ-7评分均显著降低,且观察组评分低于对照组(P<0.05)。观察组治疗有效率为95.74%(45/47),显著高于对照组的82.98%(39/47)(P<0.05)。观察组并发症以及不良反应发生率6.38%(3/47)、复发率6.38%(3/47)均显著低于对照组21.28%(10/47)、82.98%(39/47)(P<0.05)。结论应用内镜引导下咽鼓管吹张激素给药为分泌性中耳炎患者进行治疗可显著改善患者咽鼓管功能,提高临床治疗有效率以及降低相关不良反应、并发症发生率,具有较高的临床推广应用价值。Objective To analyze the effect of endoscope-guided hormone administration in secretory otitis media.Methods A total of 94 patients with secretory otitis media admitted to Shenzhen Samii Medical Center from January 2021 to December 2022 were selected as research objects and were randomly divided into control group(47 cases)and observation group(47 cases)by means of random number table.The control group was treated with conventional treatment and Bourgott's method,and the observation group was treated with conventional treatment combined with endoscope-guided pharyngoeustachian tube blowing hormone administration.the score of the seven-item Eustachian tube dysfunction questionnaire(ETDQ-7),treatment effective rate,incidence of adverse reactions and disease recurrence were compared between the two groups before and after treatment.Results Before treatment,there was no significant difference in ETDQ-7 between the two groups(P>0.05).After treatment,ETDQ-7 scores in both groups were significantly decreased,and the score in the observation group was lower than that in the control group(P<0.05).The effective rate of observation group was 95.74%(45/47),which was significantly higher than that of control group 82.98%(39/47)(P<0.05).The incidence of complications and adverse reactions[6.38%(3/47]and recurrence[6.38%(3/47)]in the observation group were significantly lower than those in the control group[21.28%(10/47)]and[82.98%(39/47)](P<0.05).Conclusion Endoscope-guided administration of eustachian tube blowing hormone for secretory otitis media patients can significantly improve the eustachian tube function,improve clinical treatment efficiency and reduce the incidence of related adverse reactions and complications,which has a high clinical application value.

关 键 词：内镜引导 咽鼓管吹张 激素 分泌性中耳炎 咽鼓管功能 波氏法咽鼓管吹张 全身给药 

分 类 号：R764[医药卫生—耳鼻咽喉科]